Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
Identifieur interne : 000117 ( Main/Exploration ); précédent : 000116; suivant : 000118Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
Auteurs : A. Kuzeva [Royaume-Uni] ; S. Dost [Royaume-Uni] ; B. Lams [Royaume-Uni] ; S. Agarwal [Royaume-Uni] ; D S Furmedge [Royaume-Uni]Source :
- British journal of hospital medicine (London, England : 2005) [ 1750-8460 ] ; 2020.
Descripteurs français
- KwdFr :
- Aggravation clinique (MeSH), Betacoronavirus (MeSH), Broncho-pneumopathie chronique obstructive (complications), Dyspnée (thérapie), Dyspnée (étiologie), Délai jusqu'au traitement (MeSH), Glucocorticoïdes (usage thérapeutique), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (traitement médicamenteux), Lymphohistiocytose hémophagocytaire (virologie), Multimorbidité (MeSH), Mâle (MeSH), Méthylprednisolone (usage thérapeutique), Oxygénothérapie (MeSH), Pandémies (MeSH), Pneumopathie virale (diagnostic), Pneumopathie virale (traitement médicamenteux), Prednisolone (usage thérapeutique), Protéine C-réactive (analyse), Récupération fonctionnelle (MeSH), Sujet âgé (MeSH).
- MESH :
- analyse : Protéine C-réactive.
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- thérapie : Dyspnée.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Glucocorticoïdes, Méthylprednisolone, Prednisolone.
- virologie : Lymphohistiocytose hémophagocytaire.
- étiologie : Dyspnée.
- complications : Aggravation clinique, Betacoronavirus, Broncho-pneumopathie chronique obstructive, Délai jusqu'au traitement, Humains, Multimorbidité, Mâle, Oxygénothérapie, Pandémies, Récupération fonctionnelle, Sujet âgé.
English descriptors
- KwdEn :
- Aged (MeSH), Betacoronavirus (MeSH), C-Reactive Protein (analysis), Clinical Deterioration (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Dyspnea (etiology), Dyspnea (therapy), Glucocorticoids (therapeutic use), Humans (MeSH), Lymphohistiocytosis, Hemophagocytic (virology), Male (MeSH), Methylprednisolone (therapeutic use), Multimorbidity (MeSH), Oxygen Inhalation Therapy (MeSH), Pandemics (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (drug therapy), Prednisolone (therapeutic use), Pulmonary Disease, Chronic Obstructive (complications), Recovery of Function (MeSH), Time-to-Treatment (MeSH).
- MESH :
- chemical , analysis : C-Reactive Protein.
- complications : Pulmonary Disease, Chronic Obstructive.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- etiology : Dyspnea.
- chemical , therapeutic use : Glucocorticoids, Methylprednisolone, Prednisolone.
- therapy : Dyspnea.
- virology : Lymphohistiocytosis, Hemophagocytic.
- Aged, Betacoronavirus, Clinical Deterioration, Humans, Male, Multimorbidity, Oxygen Inhalation Therapy, Pandemics, Recovery of Function, Time-to-Treatment.
DOI: 10.12968/hmed.2020.0372
PubMed: 32730151
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.</title><author><name sortKey="Kuzeva, A" sort="Kuzeva, A" uniqKey="Kuzeva A" first="A" last="Kuzeva">A. Kuzeva</name><affiliation wicri:level="3"><nlm:affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Dost, S" sort="Dost, S" uniqKey="Dost S" first="S" last="Dost">S. Dost</name><affiliation wicri:level="3"><nlm:affiliation>Department of General Internal Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of General Internal Medicine, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Lams, B" sort="Lams, B" uniqKey="Lams B" first="B" last="Lams">B. Lams</name><affiliation wicri:level="3"><nlm:affiliation>Department of Thoracic Medicine, Allergy and Sleep, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Thoracic Medicine, Allergy and Sleep, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Agarwal, S" sort="Agarwal, S" uniqKey="Agarwal S" first="S" last="Agarwal">S. Agarwal</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Furmedge, D S" sort="Furmedge, D S" uniqKey="Furmedge D" first="D S" last="Furmedge">D S Furmedge</name><affiliation wicri:level="3"><nlm:affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32730151</idno><idno type="pmid">32730151</idno><idno type="doi">10.12968/hmed.2020.0372</idno><idno type="wicri:Area/Main/Corpus">000923</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000923</idno><idno type="wicri:Area/Main/Curation">000923</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000923</idno><idno type="wicri:Area/Main/Exploration">000923</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.</title><author><name sortKey="Kuzeva, A" sort="Kuzeva, A" uniqKey="Kuzeva A" first="A" last="Kuzeva">A. Kuzeva</name><affiliation wicri:level="3"><nlm:affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Dost, S" sort="Dost, S" uniqKey="Dost S" first="S" last="Dost">S. Dost</name><affiliation wicri:level="3"><nlm:affiliation>Department of General Internal Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of General Internal Medicine, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Lams, B" sort="Lams, B" uniqKey="Lams B" first="B" last="Lams">B. Lams</name><affiliation wicri:level="3"><nlm:affiliation>Department of Thoracic Medicine, Allergy and Sleep, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Thoracic Medicine, Allergy and Sleep, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Agarwal, S" sort="Agarwal, S" uniqKey="Agarwal S" first="S" last="Agarwal">S. Agarwal</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Furmedge, D S" sort="Furmedge, D S" uniqKey="Furmedge D" first="D S" last="Furmedge">D S Furmedge</name><affiliation wicri:level="3"><nlm:affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">British journal of hospital medicine (London, England : 2005)</title><idno type="ISSN">1750-8460</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>C-Reactive Protein (analysis)</term><term>Clinical Deterioration (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (drug therapy)</term><term>Dyspnea (etiology)</term><term>Dyspnea (therapy)</term><term>Glucocorticoids (therapeutic use)</term><term>Humans (MeSH)</term><term>Lymphohistiocytosis, Hemophagocytic (virology)</term><term>Male (MeSH)</term><term>Methylprednisolone (therapeutic use)</term><term>Multimorbidity (MeSH)</term><term>Oxygen Inhalation Therapy (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (drug therapy)</term><term>Prednisolone (therapeutic use)</term><term>Pulmonary Disease, Chronic Obstructive (complications)</term><term>Recovery of Function (MeSH)</term><term>Time-to-Treatment (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aggravation clinique (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Broncho-pneumopathie chronique obstructive (complications)</term><term>Dyspnée (thérapie)</term><term>Dyspnée (étiologie)</term><term>Délai jusqu'au traitement (MeSH)</term><term>Glucocorticoïdes (usage thérapeutique)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Lymphohistiocytose hémophagocytaire (virologie)</term><term>Multimorbidité (MeSH)</term><term>Mâle (MeSH)</term><term>Méthylprednisolone (usage thérapeutique)</term><term>Oxygénothérapie (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Prednisolone (usage thérapeutique)</term><term>Protéine C-réactive (analyse)</term><term>Récupération fonctionnelle (MeSH)</term><term>Sujet âgé (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>C-Reactive Protein</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Protéine C-réactive</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyspnea</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Glucocorticoids</term><term>Methylprednisolone</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Dyspnea</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Dyspnée</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Glucocorticoïdes</term><term>Méthylprednisolone</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Lymphohistiocytose hémophagocytaire</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Lymphohistiocytosis, Hemophagocytic</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Dyspnée</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Betacoronavirus</term><term>Clinical Deterioration</term><term>Humans</term><term>Male</term><term>Multimorbidity</term><term>Oxygen Inhalation Therapy</term><term>Pandemics</term><term>Recovery of Function</term><term>Time-to-Treatment</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Aggravation clinique</term><term>Betacoronavirus</term><term>Broncho-pneumopathie chronique obstructive</term><term>Délai jusqu'au traitement</term><term>Humains</term><term>Multimorbidité</term><term>Mâle</term><term>Oxygénothérapie</term><term>Pandémies</term><term>Récupération fonctionnelle</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32730151</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1750-8460</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>07</Month><Day>02</Day></PubDate></JournalIssue><Title>British journal of hospital medicine (London, England : 2005)</Title><ISOAbbreviation>Br J Hosp Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.</ArticleTitle><Pagination><MedlinePgn>1-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12968/hmed.2020.0372</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuzeva</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dost</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lams</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Allergy and Sleep, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furmedge</LastName><ForeName>D S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Ageing & Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Hosp Med (Lond)</MedlineTA><NlmUniqueID>101257109</NlmUniqueID><ISSNLinking>1750-8460</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075902" MajorTopicYN="N">Clinical Deterioration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051359" MajorTopicYN="N">Lymphohistiocytosis, Hemophagocytic</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076322" MajorTopicYN="N">Multimorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32730151</ArticleId><ArticleId IdType="doi">10.12968/hmed.2020.0372</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Kuzeva, A" sort="Kuzeva, A" uniqKey="Kuzeva A" first="A" last="Kuzeva">A. Kuzeva</name></region><name sortKey="Agarwal, S" sort="Agarwal, S" uniqKey="Agarwal S" first="S" last="Agarwal">S. Agarwal</name><name sortKey="Dost, S" sort="Dost, S" uniqKey="Dost S" first="S" last="Dost">S. Dost</name><name sortKey="Furmedge, D S" sort="Furmedge, D S" uniqKey="Furmedge D" first="D S" last="Furmedge">D S Furmedge</name><name sortKey="Lams, B" sort="Lams, B" uniqKey="Lams B" first="B" last="Lams">B. Lams</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000117 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000117 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32730151
|texte= Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32730151" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |